Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003061777 | SCV002455506 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363671 | SCV002666270 | uncertain significance | Cardiovascular phenotype | 2019-09-05 | criteria provided, single submitter | clinical testing | The c.6793-4G>A intronic variant results from a G to A substitution 4 nucleotides upstream from coding exon 45 in the RYR2 gene. This nucleotide position is not well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004005473 | SCV004842028 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-12-13 | criteria provided, single submitter | clinical testing |